WASHINGTON — The next year at the Food and Drug Administration is going to make Robert Califf’s marathon confirmation process look easy.
The longtime Duke cardiologist, who was narrowly confirmed by the Senate Tuesday, inherits an agency that is smack dab in the middle of deliberations over a slew of controversial applications for everything from pediatric Covid-19 vaccines to ALS drugs.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
